Explain thyroid in full detail as per surgery
thyroid gland anatomy surgical diagram lobes isthmus

Anatomical specimen photograph of a human thyroid gland post-total thyroidectomy, set against a blue surgical background. The specimen is labeled to demonstrate a rare anatomical variation: bilateral pyramidal lobes. Centrally, the isthmus connects the voluminous right and left lateral lobes. Arising superiorly from the junction points between the isthmus and each lateral lobe are two distinct, elongated, conical structures identified as the right and left pyramidal lobes. The entire gland exhibits a reddish-brown, glistening parenchyma with a multinodular texture consistent with toxic multinodular goiter. The anatomical landmarks are labeled with white text: 'Right Lobe', 'Left Lobe', 'Isthmus', 'Right pyramidal lobe', and 'Left pyramidal lobe'. This clinical photograph is highly relevant for endocrine surgery and gross anatomy education, highlighting developmental remnants of the thyroglossal duct and the necessity of complete dissection during thyroidectomy to ensure total removal of all functional thyroid tissue.

This medical visual demonstrates volumetric segmentation of the thyroid gland using specialized medical imaging software. Image (a) presents a 3D reconstruction overlay on a CT-derived skeletal model of the neck and upper thorax. The segmentation highlights the anatomical lobes: the right thyroid lobe is colored green, the left lobe is red, and the isthmus/central region is purple. Image (b) shows a corresponding axial CT slice at the level of the thyroid. In this cross-sectional view, the colored segmentation masks (red for left lobe, green for right lobe, and purple for the central isthmus) are superimposed on the soft tissue structures anterior to the trachea. The image illustrates the application of semi-automated graph-cut algorithms for preoperative planning in endocrine surgery, specifically for thyroid lobectomy. Key anatomical landmarks visible include the trachea, carotid arteries, jugular veins, and cervical vertebrae. This content is designed for intermediate to advanced medical training in radiology and surgical oncology, focusing on thyroid anatomy and computer-assisted volumetric measurement.

This clinical photograph captures an intraoperative view of the neck during a surgical thyroid exploration, illustrating a rare congenital anomaly: agenesis of the thyroid isthmus. The image displays two distinct, enlarged, reddish-brown thyroid lobes situated laterally within the surgical field. Crucially, there is a complete absence of the central isthmus that typically connects the two lobes across the midline. Between the separated lobes, the cartilaginous rings of the trachea are clearly exposed and visible medially. The thyroid lobes exhibit a glistening, irregular surface texture with focal areas of hemorrhage, consistent with surgical manipulation in a patient with Graves' disease. The surgical field is stabilized with medical gauze, providing high contrast for the anatomical structures. This visual serves as a key educational example for endocrine surgeons and students to recognize anatomical variations of the thyroid gland that may be encountered during total thyroidectomy or other cervical procedures.
thyroidectomy surgical technique recurrent laryngeal nerve parathyroid

Two-panel clinical photograph illustrating the preservation of the inferior right parathyroid gland and recurrent laryngeal nerve (RLN) during a thyroidectomy surgical procedure using the Fang’s capillary fascia preservation technique. Panel A shows the operative field after raising the right thyroid lobe (black arrow), revealing the inferior parathyroid gland (white arrow) and its associated blood supply (blue arrow) in situ. Panel B demonstrates the further dissection and mobilization of tissue to protect vital structures. The sternothyroid ligament is manipulated to expose a fan-like surgical plane. Key landmarks identified include the superiorly positioned thyroid lobe (black arrow), the inferior parathyroid gland (white arrow), its distinct vascular pedicle (blue arrow), and the recurrent laryngeal nerve (yellow arrow) running in close proximity within the tracheoesophageal groove. The images emphasize the importance of identifying and maintaining the microvascular supply to the parathyroid glands and avoiding mechanical or electrical injury to the RLN during Level VI lymph node dissection. This material is intended for endocrine surgery and surgical anatomy education.

This clinical photograph shows an intraoperative view of a thyroidectomy, specifically highlighting the dissection and preservation of critical neurovascular and glandular structures. The thyroid gland is superiorly retracted. Below it, the Superior Parathyroid Gland (SPG) is identified and carefully protected. The Recurrent Laryngeal Nerve (RLN) is clearly visualized running parallel and superficial to the Common Carotid Artery (CCA). Surgical instrumentation, including dissecting forceps and a specialized thermal or ultrasonic cutting device, is being used to perform precise dissection in the tracheoesophageal groove. The image demonstrates the 'upward separation' technique aimed at isolating the thyroid lobe while maintaining the integrity of the RLN and vascular supply to the parathyroid glands. This educational visual emphasizes surgical anatomy and safety protocols for residents and surgeons performing endocrine neck surgery.

This clinical photograph displays an intraoperative view of a thyroidectomy during a recurrent laryngeal nerve (RLN) dissection, captured under 2.5x optical magnification. The surgical field highlights critical anatomical structures labeled as follows: (A) the reddish-brown, lobulated thyroid gland parenchyma; (B) the right-sided recurrent laryngeal nerve, identified as a slender, yellowish-white string-like structure outlined in blue; and (C) the inferior parathyroid gland, appearing as a small, beige-colored nodule in close proximity to the thyroid and nerve. Surgical instruments including a metallic hemostat and a blue suture thread are visible, facilitating tissue retraction and identification. White surgical gauze and metallic retractors define the periphery of the operative site. This image serves as an educational tool for endocrine surgery, illustrating the precise identification and preservation of the RLN and parathyroid glands to prevent postoperative complications such as vocal cord paralysis and hypocalcemia.
thyroid cancer papillary follicular medullary anaplastic classification

This line graph illustrates the epidemiological trends in the distribution of thyroid cancer cases by histological type from 1980 to 2012. The data, expressed as a percentage of all thyroid cancer cases, shows a prominent increase in papillary carcinoma, which rose from approximately 60% in 1980 to over 90% by 2012. Conversely, other histological subtypes show a steady decline in relative proportion over the same period. Follicular carcinoma, which initially accounted for nearly 25% of cases, decreased significantly. Medullary and anaplastic carcinomas, along with a category labeled as 'others,' remained at low percentages and trended downward toward the end of the study period. This visualization emphasizes the shifting landscape of thyroid pathology, highlighting the increasing dominance of papillary carcinoma in clinical diagnosis and incidence relative to non-papillary types. The graph serves as an educational resource for oncology and endocrinology, illustrating longitudinal changes in cancer subtypes within a specific population context.

This line graph illustrates a joinpoint analysis of time trends for the age-standardized incidence of non-papillary thyroid cancer (including follicular, medullary, and anaplastic histological types) in Israel from 1980 to 2012. The data is stratified by gender within the Jewish population. The y-axis represents the rate per 100,000, while the x-axis denotes the calendar years. The visual demonstrates a statistically significant downward trend in the incidence for both Jewish women and Jewish men over the 32-year period. Jewish women (indicated by the upper green line) started with a higher incidence rate in 1980 compared to Jewish men (indicated by the lower blue line). Both groups show fluctuations year-over-year but exhibit a clear overall decline, with incidence rates narrowing and approaching lower, more similar values by 2012. This epidemiological data highlights shifting patterns in thyroid cancer pathology, contrasting the decreasing incidence of non-papillary types with the concurrent rise of papillary carcinoma observed in the same period.
| Anomaly | Description |
|---|---|
| Thyroglossal duct cyst | Most common; midline, moves with tongue protrusion |
| Ectopic thyroid | Lingual thyroid; only thyroid tissue in 70% |
| Pyramidal lobe | Present in 50% of individuals, remnant of thyroglossal duct |
| Aplasia/Hypoplasia | Rare; causes congenital hypothyroidism |


| Test | Purpose |
|---|---|
| TSH | Best screening test; suppressed in hyperthyroidism, elevated in hypothyroidism |
| Free T4 | Directly measures unbound active hormone |
| T3 | Useful in T3 toxicosis |
| Anti-TPO, Anti-Tg antibodies | Hashimoto's thyroiditis |
| TSH receptor antibodies (TRAb) | Graves' disease |
| Calcitonin | Medullary thyroid cancer screening |
| CEA | Medullary thyroid cancer |
| Bethesda | Category | Malignancy Risk | Management |
|---|---|---|---|
| I | Non-diagnostic | 5-10% | Repeat FNA |
| II | Benign | 0-3% | Follow-up |
| III | AUS/FLUS | 6-18% | Repeat FNA or molecular testing |
| IV | Follicular neoplasm | 10-40% | Lobectomy |
| V | Suspicious for malignancy | 45-75% | Lobectomy/thyroidectomy |
| VI | Malignant | 94-96% | Thyroidectomy |
| Type | Features | Surgery? |
|---|---|---|
| Hashimoto's | Autoimmune, hypothyroidism | Only for suspicion of malignancy |
| De Quervain's (subacute granulomatous) | Viral, painful, transient hyperthyroidism then hypothyroidism | No |
| Riedel's (fibrous) | "Woody" hard thyroid, invasive fibrosis, IgG4-related | Wedge excision of isthmus to decompress trachea |
| Type | Frequency | Origin | Features |
|---|---|---|---|
| Papillary | 80-85% | Follicular cells | Psammoma bodies, nuclear grooves, orphan Annie nuclei; lymphatic spread; best prognosis |
| Follicular | 10-15% | Follicular cells | Vascular + capsular invasion; hematogenous spread (bone, lung); FNA cannot distinguish from adenoma |
| Medullary | 5-8% | C-cells | Calcitonin secretion; RET proto-oncogene; MEN2A/2B; amyloid stroma |
| Anaplastic | 1-2% | Follicular cells | Most aggressive; often in elderly women; presents with rapid painful neck mass; median survival < 6 months |
| Lymphoma | <1% | B-cells | Associated with Hashimoto's; MALT or diffuse large B-cell; chemotherapy ± radiation, not surgery |
| Procedure | Extent | Indications |
|---|---|---|
| Thyroid lobectomy | One lobe ± isthmus | Unilateral nodule, follicular neoplasm, PTC <1-4 cm (low risk), toxic adenoma |
| Near-total thyroidectomy | >95% of thyroid removed | Benign bilateral disease |
| Total thyroidectomy | Entire gland | Thyroid cancer, Graves' disease, large MNG, completion after lobectomy |
| Subtotal thyroidectomy | Bilateral, leaving remnants | Historical; less used today |

| Drug | Target | Indication |
|---|---|---|
| Sorafenib | RET, VEGFR, RAF | RAI-refractory differentiated thyroid cancer |
| Lenvatinib | RET, VEGFR, FGFR, PDGFR | RAI-refractory DTC (PFS benefit +15.7 months vs placebo) |
| Vandetanib | RET, VEGFR, EGFR | Progressive MTC |
| Cabozantinib | RET, VEGFR, MET | Progressive MTC |
| Dabrafenib + Trametinib | BRAF + MEK | BRAF V600E-mutated ATC |
| Selpercatinib | RET | RET-mutated thyroid cancer |
| Level | Anatomical Location |
|---|---|
| I | Submental + submandibular |
| II | Upper jugular |
| III | Middle jugular |
| IV | Lower jugular |
| V | Posterior triangle |
| VI | Central (pretracheal, paratracheal, prelaryngeal = Delphian) |
| VII | Superior mediastinum |